John Havelick, Jr

Title: John Havelick, Jr: Innovator in Medical Applications

Introduction

John Havelick, Jr. is a notable inventor based in Wakefield, MA (US). He has made significant contributions to the field of medical and biological applications through his innovative work. His research focuses on the preparation and use of novel injectable RES agents that enhance medical imaging and therapeutic delivery.

Latest Patents

Havelick holds a patent for the "Preparation and use of novel injectable RES avoiding inorganic particles." This patent describes the development of novel N-RES agents for in vitro and in vivo applications, including MRI and intravenous administration of pharmaceutical agents. The agents are created by coating inorganic core particles with a poly(acrylic acid)--poly(alkylene ether) graft copolymer. The resulting polymer-coated inorganic particle cores serve as imaging and therapeutic agents, offering increased circulation time due to reduced uptake or recognition by the RES.

Career Highlights

Havelick is currently associated with Bioquest, Inc., where he continues to advance his research in medical applications. His work has the potential to significantly impact the field of medical imaging and drug delivery systems.

Collaborations

Some of his notable coworkers include Mark S. Chagnon and Stephen E. Burkle, who have collaborated with him on various projects within the company.

Conclusion

John Havelick, Jr. is a distinguished inventor whose innovative contributions to medical applications are paving the way for advancements in imaging and therapeutic techniques. His work exemplifies the importance of innovation in enhancing healthcare solutions.